These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 28269951)

  • 1. Literature-Based Discovery of Confounding in Observational Clinical Data.
    Malec SA; Wei P; Xu H; Bernstam EV; Myneni S; Cohen T
    AMIA Annu Symp Proc; 2016; 2016():1920-1929. PubMed ID: 28269951
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Using computable knowledge mined from the literature to elucidate confounders for EHR-based pharmacovigilance.
    Malec SA; Wei P; Bernstam EV; Boyce RD; Cohen T
    J Biomed Inform; 2021 May; 117():103719. PubMed ID: 33716168
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Standard-based comprehensive detection of adverse drug reaction signals from nursing statements and laboratory results in electronic health records.
    Lee S; Choi J; Kim HS; Kim GJ; Lee KH; Park CH; Han J; Yoon D; Park MY; Park RW; Kang HR; Kim JH
    J Am Med Inform Assoc; 2017 Jul; 24(4):697-708. PubMed ID: 28087585
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A reference standard for evaluation of methods for drug safety signal detection using electronic healthcare record databases.
    Coloma PM; Avillach P; Salvo F; Schuemie MJ; Ferrajolo C; Pariente A; Fourrier-Réglat A; Molokhia M; Patadia V; van der Lei J; Sturkenboom M; Trifirò G
    Drug Saf; 2013 Jan; 36(1):13-23. PubMed ID: 23315292
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 3D pharmacophoric similarity improves multi adverse drug event identification in pharmacovigilance.
    Vilar S; Tatonetti NP; Hripcsak G
    Sci Rep; 2015 Mar; 5():8809. PubMed ID: 25744369
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A method for controlling complex confounding effects in the detection of adverse drug reactions using electronic health records.
    Li Y; Salmasian H; Vilar S; Chase H; Friedman C; Wei Y
    J Am Med Inform Assoc; 2014; 21(2):308-14. PubMed ID: 23907285
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Natural Language Processing for EHR-Based Pharmacovigilance: A Structured Review.
    Luo Y; Thompson WK; Herr TM; Zeng Z; Berendsen MA; Jonnalagadda SR; Carson MB; Starren J
    Drug Saf; 2017 Nov; 40(11):1075-1089. PubMed ID: 28643174
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identifying plausible adverse drug reactions using knowledge extracted from the literature.
    Shang N; Xu H; Rindflesch TC; Cohen T
    J Biomed Inform; 2014 Dec; 52():293-310. PubMed ID: 25046831
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Using Rich Data on Comorbidities in Case-Control Study Design with Electronic Health Record Data Improves Control of Confounding in the Detection of Adverse Drug Reactions.
    Backenroth D; Chase H; Friedman C; Wei Y
    PLoS One; 2016; 11(10):e0164304. PubMed ID: 27716785
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of a Controlled Vocabulary-Based Adverse Drug Reaction Signal Dictionary for Multicenter Electronic Health Record-Based Pharmacovigilance.
    Lee S; Han J; Park RW; Kim GJ; Rim JH; Cho J; Lee KH; Lee J; Kim S; Kim JH
    Drug Saf; 2019 May; 42(5):657-670. PubMed ID: 30649749
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Classification-by-Analogy: Using Vector Representations of Implicit Relationships to Identify Plausibly Causal Drug/Side-effect Relationships.
    Mower J; Subramanian D; Shang N; Cohen T
    AMIA Annu Symp Proc; 2016; 2016():1940-1949. PubMed ID: 28269953
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of Electronic Health Record Data for Drug Safety Signal Identification: A Scoping Review.
    Davis SE; Zabotka L; Desai RJ; Wang SV; Maro JC; Coughlin K; Hernández-Muñoz JJ; Stojanovic D; Shah NH; Smith JC
    Drug Saf; 2023 Aug; 46(8):725-742. PubMed ID: 37340238
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structured assessment for prospective identification of safety signals in electronic medical records: evaluation in the health improvement network.
    Cederholm S; Hill G; Asiimwe A; Bate A; Bhayat F; Persson Brobert G; Bergvall T; Ansell D; Star K; Norén GN
    Drug Saf; 2015 Jan; 38(1):87-100. PubMed ID: 25539877
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Method to Combine Signals from Spontaneous Reporting Systems and Observational Healthcare Data to Detect Adverse Drug Reactions.
    Li Y; Ryan PB; Wei Y; Friedman C
    Drug Saf; 2015 Oct; 38(10):895-908. PubMed ID: 26153397
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Comparison Study of Algorithms to Detect Drug-Adverse Event Associations: Frequentist, Bayesian, and Machine-Learning Approaches.
    Pham M; Cheng F; Ramachandran K
    Drug Saf; 2019 Jun; 42(6):743-750. PubMed ID: 30762164
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection of pharmacovigilance-related adverse events using electronic health records and automated methods.
    Haerian K; Varn D; Vaidya S; Ena L; Chase HS; Friedman C
    Clin Pharmacol Ther; 2012 Aug; 92(2):228-34. PubMed ID: 22713699
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Making fair comparisons in pregnancy medication safety studies: An overview of advanced methods for confounding control.
    Wood ME; Lapane KL; van Gelder MMHJ; Rai D; Nordeng HME
    Pharmacoepidemiol Drug Saf; 2018 Feb; 27(2):140-147. PubMed ID: 29044735
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Pharmacovigilance in Germany : It is about time].
    Douros A; Schaefer C; Kreutz R; Garbe E
    Internist (Berl); 2016 Jun; 57(6):616-23. PubMed ID: 27224991
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Data mining methodology for response to hypertension symptomology-application to COVID-19-related pharmacovigilance.
    Xu X; Kawakami J; Millagaha Gedara NI; Riviere JE; Meyer E; Wyckoff GJ; Jaberi-Douraki M
    Elife; 2021 Nov; 10():. PubMed ID: 34812146
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.